Ohio Public Employees Retirement System (OPERS)
RPRX icon

Ohio Public Employees Retirement System (OPERS)’s Royalty Pharma RPRX Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.84M Buy
139,790
+2,779
+2% +$145K 0.02% 541
2026
Q1 		$6.57M Sell
137,011
-10,515
-7% -$461K 0.02% 572
2025
Q4 		$5.7M Buy
147,526
+4,816
+3% +$184K 0.02% 665
2025
Q3 		$5.03M Sell
142,710
-1,423
-1% -$51.5K 0.02% 700
2025
Q2 		$5.19M Buy
144,133
+4,755
+3% +$158K 0.02% 667
2025
Q1 		$4.34M Sell
139,378
-12,205
-8% -$387K 0.02% 716
2024
Q4 		$3.87M Buy
151,583
+6,454
+4% +$171K 0.01% 813
2024
Q3 		$4.11M Sell
145,129
-18,725
-11% -$519K 0.02% 741
2024
Q2 		$4.32M Buy
163,854
+7,375
+5% +$204K 0.02% 659
2024
Q1 		$4.75M Sell
156,479
-13,217
-8% -$390K 0.02% 630
2023
Q4 		$4.77M Buy
169,696
+16,398
+11% +$451K 0.02% 643
2023
Q3 		$4.16M Sell
153,298
-16,484
-10% -$490K 0.02% 642
2023
Q2 		$5.22M Sell
169,782
-19,538
-10% -$662K 0.02% 596
2023
Q1 		$6.82M Sell
189,320
-4,948
-3% -$183K 0.03% 495
2022
Q4 		$7.68M Buy
194,268
+4,672
+2% +$195K 0.03% 445
2022
Q3 		$7.62M Buy
189,596
+3,869
+2% +$165K 0.03% 446
2022
Q2 		$7.81M Sell
185,727
-50,414
-21% -$2.07M 0.03% 458
2022
Q1 		$9.2M Buy
236,141
+60,202
+34% +$2.36M 0.03% 485
2021
Q4 		$7.01M Sell
175,939
-6,360
-3% -$247K 0.02% 606
2021
Q3 		$6.59M Sell
182,299
-3,772
-2% -$147K 0.02% 625
2021
Q2 		$7.63M Buy
186,071
+14,232
+8% +$605K 0.03% 575
2021
Q1 		$7.5M Buy
171,839
+118,373
+221% +$5.61M 0.03% 532
2020
Q4 		$2.68M Buy
+53,466
New +$2.27M 0.01% 901

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s RPRX Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) increased its Royalty Pharma (RPRX) stake by 2% in Q2 2026, buying an estimated $145K and bringing the position to 139,790 shares worth $7.84M. The position accounts for 0.02% of the portfolio, ranked #541.

Ohio Public Employees Retirement System (OPERS) first reported a position in RPRX in Q4 2020 and has held it in 23 quarters since. The position peaked at $9.2M in Q1 2022. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) held 139,790 shares of Royalty Pharma worth $7.84M as of Q2 2026.
  • Ohio Public Employees Retirement System (OPERS) bought 2,779 Royalty Pharma shares in Q2 2026, an estimated $145K.
  • Royalty Pharma made up 0.02% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #541 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Royalty Pharma in Q4 2020 and has held it in 23 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Royalty Pharma position peaked at $9.2M in Q1 2022.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.